← The Wire
PCVXNasdaq
Vaxcyte, Inc.
Biological Products, (No Diagnostic Substances) · DE · CIK 1649094
Vaxcyte engineers high-fidelity vaccines using cell-free synthesis to combat bacterial diseases
red 8-K · 90d
$6.85B
Market cap
$57.72
Last close
+2.1%
1D
+10.8%
5D
2.8M
Volume
Price · last 39 sessions-1.3%
May 4L $45.42 · H $58.49Jun 29
126
Total filings
Jun 23, 2026
Last filing
12/31
Fiscal year end
8-KExecutive ChangeJun 23, 20268-KShareholder VoteJun 16, 202610-Q10-QMay 6, 20268-KResults of OperationsMay 6, 2026DEFA14ADEFA14AApr 23, 2026DEF 14ADEF 14AApr 23, 20268-KCompany UpdateFeb 24, 2026424B5424B5Feb 24, 202610-K10-KFeb 24, 20268-KResults of OperationsFeb 24, 20268-KCompany UpdateFeb 2, 2026424B5424B5Jan 30, 2026424B5424B5Jan 29, 20268-KExecutive ChangeDec 19, 202510-Q10-QNov 4, 20258-KResults of OperationsNov 4, 20258-KMaterial AgreementSep 30, 202510-Q10-QAug 6, 20258-KResults of OperationsAug 6, 20258-KShareholder VoteJun 17, 202510-Q10-QMay 7, 20258-KResults of OperationsMay 7, 20258-KExecutive ChangeMay 1, 2025DEFA14ADEFA14AApr 28, 2025DEF 14ADEF 14AApr 28, 20258-KReg FD Disclosure · Company UpdateMar 31, 202510-K10-KFeb 25, 20258-KResults of OperationsFeb 25, 20258-KMaterial Agreement · Company UpdateNov 21, 202410-Q10-QNov 5, 20248-KResults of OperationsNov 5, 20248-KCompany UpdateSep 6, 2024424B5424B5Sep 5, 2024424B5424B5Sep 3, 20248-KReg FD Disclosure · Company UpdateSep 3, 202410-Q10-QAug 6, 20248-KResults of OperationsAug 6, 20248-KExecutive ChangeJul 2, 20248-KShareholder VoteJun 10, 202410-Q10-QMay 8, 20248-KResults of OperationsMay 8, 2024DEFA14ADEFA14AApr 15, 2024DEF 14ADEF 14AApr 15, 202410-K10-KFeb 27, 20248-KResults of OperationsFeb 27, 2024424B5424B5Jan 31, 20248-KCompany UpdateJan 31, 2024424B5424B5Jan 30, 20248-KExecutive ChangeNov 28, 20238-KMaterial AgreementNov 27, 202310-Q10-QNov 6, 20238-KResults of OperationsNov 6, 20238-KMaterial AgreementOct 16, 20238-KMaterial AgreementOct 4, 20238-KMaterial AgreementSep 7, 202310-Q10-QAug 8, 20238-KResults of OperationsAug 8, 20238-KShareholder VoteJun 15, 202310-Q10-QMay 8, 20238-KResults of OperationsMay 8, 2023DEFA14ADEFA14AApr 28, 2023DEF 14ADEF 14AApr 28, 2023424B5424B5Apr 20, 20238-KCompany UpdateApr 20, 2023424B5424B5Apr 17, 20238-KCompany UpdateApr 17, 20238-KMaterial AgreementMar 6, 2023424B5424B5Feb 27, 20238-KCompany UpdateFeb 27, 202310-K10-KFeb 27, 20238-KResults of OperationsFeb 27, 2023SC 13GSC 13GFeb 3, 20238-KMaterial AgreementDec 20, 20228-KExecutive ChangeDec 12, 20228-KResults of OperationsNov 7, 202210-Q10-QNov 7, 2022424B5424B5Oct 27, 20228-KCompany UpdateOct 27, 2022424B5424B5Oct 24, 20228-KCompany UpdateOct 24, 2022
Insider Activity
In the 90 days to Mar 17, 2026: 3 sold $1.7M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 17, 2026 | Cowan ElviaSVP, Finance & CAO | Sell | 1,487 | $55.39 | $82K |
| Mar 17, 2026 | Cowan ElviaSVP, Finance & CAO | Sell | 405 | $56.26 | $23K |
| Mar 11, 2026 | Cowan ElviaSVP, Finance & CAO | Sell | 2,500 | $58.59 | $146K |
| Mar 10, 2026 | Wassil JimCHIEF OPERATING OFFICER | Sell | 4,968 | $59.16 | $294K |
| Mar 10, 2026 | Wassil JimCHIEF OPERATING OFFICER | Sell | 2,427 | $58.32 | $142K |
| Dec 31, 2025 | Dhaliwal Harpreet S.Chief Technical Ops Officer | Sell | 9,743 | $46.69 | $455K |
| Dec 23, 2025 | Cowan ElviaSVP, FINANCE | Sell | 6,716 | $47.94 | $322K |
| Dec 23, 2025 | Cowan ElviaSVP, FINANCE | Sell | 4,907 | $47.90 | $235K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
In the News
Reputable outlets only (Reuters, WSJ, CNBC, Barron's, and peers). More on Google News ↗
Similar companies
Comparable business profile · signals at a glance